When is Protein Binding Important?

被引:60
|
作者
Heuberger, Jules [1 ]
Schmidt, Stephan [1 ]
Derendorf, Hartmut [1 ]
机构
[1] Univ Florida, Dept Pharmaceut, Gainesville, FL 32611 USA
关键词
protein binding; in vitro/in vivo correlations (IVIVC); drug interaction; pharmacokinetics; in vitro models; microdialysis; HEPATIC METABOLIC-CLEARANCE; DRUG-DRUG INTERACTIONS; IN-VITRO DATA; HUMAN LIVER-MICROSOMES; NONSPECIFIC-BINDING; INTRINSIC CLEARANCE; DISPLACEMENT INTERACTIONS; PHARMACOLOGICAL-ACTIVITY; CLINICAL-SIGNIFICANCE; INHALED CICLESONIDE;
D O I
10.1002/jps.23559
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present paper is an ode to a classic citation by Benet and Hoener (2002. Clin Pharm Ther 71(3): 115-121). The now classic paper had a huge impact on drug development and the way the issue of protein binding is perceived and interpreted. Although the authors very clearly pointed out the limitations and underlying assumptions for their delineations, these are too often overlooked and the classic paper's message is misinterpreted by broadening to cases that were not intended. Some members of the scientific community concluded from the paper that protein binding is not important. This was clearly not intended by the authors, as they finished their paper with a paragraph entitled: "When is protein binding important?" Misinterpretation of the underlying assumptions in the classic work can result in major pitfalls in drug development. Therefore, we revisit the topic of protein binding with the intention of clarifying when clinically relevant changes should be considered during drug development. (C) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102: 3458-3467, 2013
引用
收藏
页码:3458 / 3467
页数:10
相关论文
共 50 条
  • [41] CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity
    Jules, Joel
    Chen, Wei
    Feng, Xu
    Li, Yi-Ping
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (31) : 16390 - 16403
  • [42] The RNA-binding protein Hfq is important for ribosome biogenesis and affects translation fidelity
    dos Santos, R. F.
    Andrade, J. M.
    Chelysheva, I.
    Ignatova, Z.
    Arraiano, C. M.
    FEBS OPEN BIO, 2019, 9 : 23 - 24
  • [43] Structure-function analysis of residues important in zinc binding and activity in protein farnesyltransferase
    Fu, HW
    Casey, PJ
    FASEB JOURNAL, 1997, 11 (09): : A964 - A964
  • [44] Protein binding of rifampicin is not saturated when using high-dose rifampicin
    Litjens, Carlijn H. C.
    Aarnoutse, Rob E.
    Kolmer, Eleonora W. J. van Ewijk-Beneken
    Svensson, Elin M.
    Colbers, Angela
    Burger, David M.
    Boeree, Martin J.
    te Brake, Lindsey H. M.
    Aarnoutse, Rob
    Boeree, Martin
    Heinrich, Norbert
    Diacon, Andreas
    Dawson, Rodney
    Rehal, Sunita
    Kibiki, Gibson
    Churchyard, Gavin
    Sanne, Ian
    Ntinginya, Nyanda
    Minja, Lilian
    Hunt, Robert
    Charalambous, Salome
    Hanekom, Madeleine
    Semvua, Hadija
    Mpagama, Stellah
    Manyama, Christina
    Mtafya, Bariki
    Reither, Klaus
    Wallis, Robert
    Venter, Amour
    Narunsky, Kim
    Mekota, Anna-Maria
    Henne, Sonja
    van Balen, Georgette Plemper
    Gillespie, Stephen
    Phillips, Patrick
    Hoelscher, Michael
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (04) : 986 - 990
  • [45] What Are Species Pools and When Are They Important?
    Cornell, Howard V.
    Harrison, Susan P.
    ANNUAL REVIEW OF ECOLOGY, EVOLUTION, AND SYSTEMATICS, VOL 45, 2014, 45 : 45 - 67
  • [46] Cardiac Enzymes: When Is a Positive Important?
    Smith, Lesa
    Norman, Karen
    CRITICAL CARE NURSE, 2015, 35 (02) : E64 - E65
  • [47] WHEN IS THE DEMAND FACTOR OF LOCATION IMPORTANT
    GREENHUT, ML
    LAND ECONOMICS, 1964, 40 (02) : 175 - 184
  • [48] When is downstream pathway inhibition important?
    Wilson, Sheridan
    Chia, Stephen K.
    LANCET ONCOLOGY, 2014, 15 (06): : 541 - 542
  • [49] The battle of the sexes when the future is important
    Hausken, K
    ECONOMICS LETTERS, 2005, 87 (01) : 89 - 93
  • [50] HYPOGLYCEMIA IN THE NEONATE - HOW AND WHEN IS IT IMPORTANT
    LAND, JM
    DEVELOPMENTAL NEUROSCIENCE, 1994, 16 (5-6) : 307 - 312